| Clinical development of targeted and immune based anti-cancer therapies NA Seebacher, AE Stacy, GM Porter, AM Merlot Journal of Experimental & Clinical Cancer Research 38 (1), 156, 2019 | 259 | 2019 |
| Molecular pharmacology of ABCG2 and its role in chemoresistance AE Stacy, PJ Jansson, DR Richardson Molecular pharmacology 84 (5), 655-669, 2013 | 249 | 2013 |
| Zinc (II)–thiosemicarbazone complexes are localized to the lysosomal compartment where they transmetallate with copper ions to induce cytotoxicity AE Stacy, D Palanimuthu, PV Bernhardt, DS Kalinowski, PJ Jansson, ... Journal of medicinal chemistry 59 (10), 4965-4984, 2016 | 178 | 2016 |
| Di-2-pyridylketone 4, 4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp) PJ Jansson, T Yamagishi, A Arvind, N Seebacher, E Gutierrez, A Stacy, ... Journal Of Biological Chemistry 290 (15), 9588-9603, 2015 | 139 | 2015 |
| Structure–activity relationships of di-2-pyridylketone, 2-benzoylpyridine, and 2-acetylpyridine thiosemicarbazones for overcoming Pgp-mediated drug resistance AE Stacy, D Palanimuthu, PV Bernhardt, DS Kalinowski, PJ Jansson, ... Journal of Medicinal Chemistry 59 (18), 8601-8620, 2016 | 100 | 2016 |
| Tumour microenvironment stress promotes the development of drug resistance NA Seebacher, M Krchniakova, AE Stacy, J Skoda, PJ Jansson Antioxidants 10 (11), 1801, 2021 | 53 | 2021 |
| Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis SL Stocker, JE Carland, SE Reuter, AE Stacy, AL Schaffer, M Stefani, ... Clinical Pharmacology & Therapeutics 109 (1), 212-221, 2021 | 23 | 2021 |
| Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin JE Carland, AE Stacy, AL Schaffer, RO Day, J Brett, SE Reuter, ... British Journal of Clinical Pharmacology 89 (6), 1896-1902, 2023 | | 2023 |
| Cancer stem cell marker profile of human melanoma biopsies N Seebacher, SD Smith, A Stacy, P Jansson, M Middleton AUSTRALASIAN JOURNAL OF DERMATOLOGY 63, 98-99, 2022 | | 2022 |
| Cancer stem cell gene signature defines response to immune checkpoint inhibitors in melanoma patients NA Seebacher, AE Stacy, PJJ Jansson, J Wilmott, M Middleton ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17, 67-67, 2021 | | 2021 |
| 261 Distinct Melanoma Cancer Stem Cell Profile Defines Response to Immune Checkpoint Inhibitors in Melanomas N Seebacher, A Stacy, J Wilmott, P Jansson, M Middleton Journal of Investigative Dermatology 141 (10), S193, 2021 | | 2021 |
| Thiosemicarbazones Target Multiple Resistance Pathways in Cancer AE Stacy | | 2016 |
| Zinc (II)-Thiosemicarbazone Complexes Are Localized to the Lysosomal Compartment Where They Transmetallate with Copper Ions to Induce Cytotoxicity P Jansson, D Kalinowski, D Palanimuthu, DD Richardson, AE Stacy, ... American Chemical Society, 2016 | | 2016 |
| Di-2-pyridylketone 4, 4-Dimethyl-3-thiosemicarbazone (Dp44mT) Overcomes Multidrug-Resistance by a Novel Mechanism Involving the Hijacking of Lysosomal P-Glycoprotein (Pgp … A Stacy, S Maleki, D Sharp, S Sahni, DR Richardson | | 2015 |
